Methadone Market Players:
- Eli Lilly and Company
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Sanofi S.A.
- Hikma Labs Inc.
- Mallinckrodt Pharmaceuticals
- Siegfried Holding AG
- Johnson Matthey
- Gilead Sciences, Inc.
- BioControl Medical
- Tianjin Central Pharmaceutical Industry Co., Ltd.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of methadone is assessed at USD 206.85 million.
The global methadone market size was valued at more than USD 193.93 million in 2025 and is expected to register a CAGR of over 7.4%, exceeding USD 395.99 million revenue by 2035.
North America methadone market is projected to secure a 42% revenue share, spurred by the rising incidence of drug addiction and the growing reliance on methadone for managing post-operative and substance-related pain.
Key players in the market include Eli Lilly and Company, Sanofi S.A., Hikma Labs Inc., Mallinckrodt Pharmaceuticals, Siegfried Holding AG, Johnson Matthey, Gilead Sciences, Inc., BioControl Medical, Tianjin Central Pharmaceutical Industry Co., Ltd.
